Antimicrobial Agents Practice Questions

Q: Which of the following is a true statement about Imipenem?

It is used with cilastatin.. Explanation: 1. Why Option C is correct: Imipenem is a potent carbapenem antibiotic [2]. When administered alone, it is rapidly inactivated by the enzyme Dehydropeptidase-I (DHP-I) located in the brush border of the proximal renal tubules. This metabolism results in low urinary concentrations and the formation of potentially nephrotoxic metabolites. To prevent this, Imipenem is always co-administered with Cilastatin, a specific DHP-I inhibitor. Cilastatin ensures high therapeutic levels of the drug in the urine and protects the kidneys. 2. Why other options are incorrect: * Option A: Imipenem has an extremely broad spectrum of action, covering Gram-positive, Gram-negative, and anaerobic bacteria (including Pseudomonas and Bacteroides) [2]. * Option B: Imipenem is highly resistant to most beta-lactamases, including extended-spectrum beta-lactamases (ESBLs) [2]. This makes it a "drug of last resort" for multi-drug resistant infections. * Option D: Sulbactam is a beta-lactamase inhibitor typically paired with Ampicillin [1]. It is not used with Imipenem because Imipenem is already inherently stable against most beta-lactamases. 3. High-Yield Clinical Pearls for NEET-PG: * Seizures: Imipenem is the carbapenem most likely to cause seizures as a side effect (especially in patients with renal failure). Meropenem has a lower seizure potential. * Ertapenem: Unlike Imipenem, Ertapenem lacks activity against Pseudomonas and Acinetobacter (Mnemonic: Ertapenem is Excluded from Pseudomonas). * Carbapenemases: Resistance to Imipenem is mediated by carbapenemases (e.g., NDM-1), which are treated with newer agents like Ceftazidime-Avibactam.

Q: Which drug is used for the prophylaxis of rheumatic heart disease?

All of the above. **Explanation:**The primary goal of prophylaxis in **Rheumatic Heart Disease (RHD)** is to prevent recurrent Group A Beta-hemolytic Streptococcal (GABHS) pharyngitis, which triggers the autoimmune response leading to valvular damage. **Why "All of the above" is correct:**Prophylaxis is categorized into primary (preventing the first attack) and secondary (preventing recurrences). All three drugs listed are standard options: * **Benzathine Penicillin (Option C):** This is the **drug of choice** for secondary prophylaxis [1]. It is administered as a deep intramuscular injection every 3–4 weeks. Its long-acting nature ensures sustained plasma levels, overcoming compliance issues. * **Phenoxy-methyl Penicillin (Penicillin V) (Option B):** This is the oral alternative for patients who refuse injections [1]. However, it is less preferred due to the requirement of twice-daily dosing and poor patient compliance. * **Sulfadiazine (Option A):** This is an effective oral alternative for secondary prophylaxis in patients who are **allergic to Penicillin** [2]. It is contraindicated in pregnancy and patients with G6PD deficiency. **Clinical Pearls for NEET-PG:**1. **Drug of Choice (DOC):** Benzathine Penicillin G (1.2 million units IM).2. **Duration of Prophylaxis:** * *Rheumatic fever without carditis:* 5 years or until age 21 (whichever is longer).* *With carditis but no residual heart disease:* 10 years or until age 21.* *With residual valvular disease:* 10 years or until age 40 (sometimes lifelong).3. **Macrolides (Erythromycin/Azithromycin):** Used only if the patient is allergic to both Penicillin and Sulfonamides.4. **Infective Endocarditis (IE) Prophylaxis:** Note that RHD prophylaxis is different from IE prophylaxis (where Amoxicillin is typically used before dental procedures).

Q: Which anti-tubercular agent is associated with side effects such as respiratory syndrome, cutaneous syndrome, flu-like syndrome, and abdominal syndrome?

Rifampicin. The correct answer is **Rifampicin**. These specific "syndromes" are characteristic adverse reactions associated with **intermittent (less than twice weekly) or high-dose** administration of Rifampicin [1]. **Why Rifampicin is correct:** Rifampicin-induced hypersensitivity reactions are thought to be mediated by the formation of antibodies against the drug. When the drug is taken irregularly, these reactions manifest as distinct clusters: * **Flu-like syndrome:** Fever, chills, and malaise (most common) [1]. * **Respiratory syndrome:** Breathlessness and wheezing. * **Abdominal syndrome:** Nausea, vomiting, and abdominal pain. * **Cutaneous syndrome:** Flushing, pruritus, and rash. * **Other severe effects:** Acute renal failure, hemolytic anemia, and thrombocytopenia [1]. **Why other options are incorrect:** * **PAS (Para-aminosalicylic acid):** Primarily causes severe GI intolerance and hypersensitivity (skin rash, fever), but not the specific systemic "syndromes" mentioned. * **Pyrazinamide:** Its hallmark side effects are **hyperuricemia** (leading to gout) and hepatotoxicity. * **Streptomycin:** An aminoglycoside known for **ototoxicity** (vestibular > cochlear) and nephrotoxicity. **NEET-PG High-Yield Pearls for Rifampicin:** 1. **Mechanism:** Inhibits DNA-dependent RNA polymerase. 2. **Secretions:** Causes harmless **orange-red discoloration** of urine, sweat, and tears (counsel the patient!). 3. **Enzyme Induction:** It is a potent **CYP450 inducer**, leading to significant drug interactions (e.g., failure of oral contraceptives or warfarin). 4. **Resistance:** Due to mutations in the *rpoB* gene.

Q: What is the treatment of choice for luminal infection of E. histolytica?

Paromomycin. **Explanation:** The treatment of *Entamoeba histolytica* depends on the site of infection. Amoebicides are classified into **Tissue Amoebicides** (acting in the bowel wall, liver, and other tissues) and **Luminal Amoebicides** (acting only in the intestinal lumen). **Why Paromomycin is correct:** Paromomycin is an aminoglycoside antibiotic that is not absorbed from the gastrointestinal tract. Because it remains entirely within the gut lumen, it reaches high concentrations where it directly kills trophozoites and prevents cyst formation. It is the **drug of choice for asymptomatic cyst passers** and is used to eradicate the luminal reservoir following a course of tissue amoebicides in symptomatic patients. **Analysis of Incorrect Options:** * **Metronidazole & Tinidazole:** These are Nitroimidazoles and are the drugs of choice for **invasive/tissue amoebiasis** (amoebic liver abscess or intestinal wall infection). However, they are rapidly absorbed from the small intestine and do not reach therapeutic concentrations in the colon lumen; thus, they are ineffective for eradicating luminal cysts. * **Ivermectin:** This is an antiparasitic agent used primarily for helminths (like *Strongyloides*) and ectoparasites (like Scabies). It has no activity against *E. histolytica*. **High-Yield Clinical Pearls for NEET-PG:** * **Luminal Amoebicides:** Paromomycin (preferred), Diloxanide furoate, and Iodoquinol. * **Standard Protocol:** For symptomatic amoebiasis, always follow Metronidazole (to kill tissue trophozoites) with a Luminal Amoebicide (to prevent relapse and transmission). * **Side Effect:** Paromomycin can cause GI upset and, rarely, ototoxicity if systemic absorption occurs in patients with inflammatory bowel disease.

Q: Empirical use of intravenous amphotericin B is indicated in?

Non-responding febrile neutropenia. **Explanation:** The correct answer is **Non-responding febrile neutropenia**. **1. Why it is correct:** In patients with persistent fever and neutropenia (Absolute Neutrophil Count <500/mm³) who do not respond to 4–7 days of broad-spectrum antibiotics, the risk of occult invasive fungal infections (especially *Aspergillus* and *Candida*) increases significantly. Empirical antifungal therapy with **Liposomal Amphotericin B** (or Caspofungin) is the standard of care to prevent mortality before a definitive fungal diagnosis can be made. **2. Why the other options are incorrect:** * **Candida infections:** While Amphotericin B is effective, it is usually reserved for severe or systemic candidiasis. It is not used "empirically" unless the patient is hemodynamically unstable or has failed azole therapy. * **Blastomycosis:** This is a specific fungal infection where Amphotericin B is a **definitive** treatment (for severe/CNS disease), not an empirical one. It is not a common indication for empirical use in general practice. * **Larva migrans:** This is a parasitic infection (Cutaneous or Visceral). Cutaneous larva migrans is treated with **Albendazole or Ivermectin**, not antifungals. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Binds to **ergosterol** in the fungal cell membrane, creating pores that cause leakage of intracellular contents. * **Dose-limiting Toxicity:** **Nephrotoxicity** (Azotemia). Liposomal formulations are used to reduce this risk. * **Infusion-related reactions:** "Shake and bake" (fever, chills, rigors) can be premedicated with NSAIDs or hydrocortisone. * **Electrolyte disturbances:** Commonly causes **Hypokalemia** and Hypomagnesemia.

Q: Which drug can be safely used in lactating mothers?

Erythromycin. Explanation: The safety of drugs during lactation depends on the drug’s concentration in breast milk and its potential toxicity to the infant [2]. Erythromycin is considered the safest option among the choices provided. It is excreted in breast milk in very small amounts, and the American Academy of Pediatrics (AAP) classifies it as compatible with breastfeeding. While there is a theoretical risk of infantile hypertrophic pyloric stenosis (IHPS) with systemic macrolide use, it remains a preferred choice for maternal infections.Analysis of Incorrect Options: * Chloramphenicol (Option B): It is strictly contraindicated during lactation. It can cause bone marrow suppression in the infant and carries the risk of "Gray Baby Syndrome" due to the infant's immature glucuronidation pathway [1], [3].* Ciprofloxacin (Option C): Fluoroquinolones are generally avoided during breastfeeding due to concerns regarding arthropathy and potential damage to developing cartilage in the infant.* Ampicillin (Option A): While penicillins are generally safe, they are more likely than erythromycin to cause diarrhea, candidiasis, or allergic sensitization in the nursing infant [1].High-Yield Clinical Pearls for NEET-PG: * Safe Antibiotics in Lactation: Penicillins [1], Cephalosporins, and Erythromycin.* Drugs Contraindicated in Lactation: Lithium, Radioactive isotopes, Methotrexate, Ergotamine, and Amiodarone.* Rule of Thumb: Drugs with high molecular weight, high protein binding, and low lipid solubility are less likely to cross into breast milk [2].* Tetracyclines: Usually avoided for long-term use as they may cause dental staining or inhibit bone growth in the infant [2].

Q: A patient with febrile neutropenia has a blood culture that grew Pseudomonas aeruginosa. The isolate was found to be a producer of extended-spectrum beta-lactamase (ESBL) enzyme. What is the most appropriate antimicrobial therapy?

Imipenem + amikacin. ### Explanation The correct answer is **D. Imipenem + amikacin.** **1. Why Imipenem + amikacin is correct:** The patient has a **Pseudomonas aeruginosa** infection that produces **Extended-Spectrum Beta-Lactamase (ESBL)**. ESBL enzymes hydrolyze most penicillins, cephalosporins (including 3rd and 4th generations), and monobactams. **Carbapenems** (like Imipenem or Meropenem) are the drugs of choice for ESBL-producing organisms because they are highly resistant to hydrolysis by these enzymes. In febrile neutropenia, guidelines recommend combining a potent anti-pseudonal beta-lactam with an **Aminoglycoside** (like Amikacin) for synergistic effect and to prevent the emergence of resistance. **2. Why other options are incorrect:** * **A & C (Ceftazidime/Cefpirome):** While Ceftazidime (3rd gen) and Cefpirome (4th gen) have anti-pseudomonal activity, they are inactivated by ESBL enzymes. Using them against an ESBL producer would lead to treatment failure. * **B (Aztreonam):** Aztreonam is a monobactam. Like cephalosporins, it is susceptible to degradation by ESBLs. It is typically reserved for patients with a severe penicillin allergy but is ineffective here. **3. High-Yield Clinical Pearls for NEET-PG:** * **ESBL Definition:** Enzymes that confer resistance to all 1st, 2nd, and 3rd generation cephalosporins and monobactams. * **Drug of Choice for ESBL:** Carbapenems (Imipenem, Meropenem, Ertapenem). * **Pseudomonas Coverage:** Not all carbapenems cover Pseudomonas; **Ertapenem** is the notable exception (it lacks activity against *P. aeruginosa*). * **Febrile Neutropenia:** Defined as a single oral temperature of $>38.3^\circ\text{C}$ or $>38.0^\circ\text{C}$ for 1 hour, with an Absolute Neutrophil Count (ANC) $<500$ cells/$\text{mm}^3$. Empiric therapy must always cover *Pseudomonas*.

Q: Which of the following is contraindicated in a patient with Myasthenia Gravis?

Aminoglycosides. **Explanation:** **1. Why Aminoglycosides are Contraindicated:** Myasthenia Gravis (MG) is an autoimmune disorder characterized by antibodies against nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction (NMJ), leading to muscle weakness. **Aminoglycosides** (e.g., Gentamicin, Neomycin, Streptomycin) are known to exacerbate MG because they interfere with neuromuscular transmission via two mechanisms: * **Presynaptic inhibition:** They inhibit the release of Acetylcholine (ACh) from the motor nerve terminal by competing with Calcium ions at the voltage-gated calcium channels. * **Postsynaptic blockade:** They decrease the sensitivity of the postsynaptic membrane to ACh. In a patient already lacking functional receptors, this further reduction in ACh release can precipitate a life-threatening **Myasthenic Crisis**. **2. Why other options are incorrect:** * **Sulfonamides and Penicillins:** These classes of antibiotics do not interfere with the neuromuscular junction or calcium signaling. They are generally considered safe for use in patients with Myasthenia Gravis. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Other Drugs to Avoid in MG:** * **Antibiotics:** Fluoroquinolones (Ciprofloxacin), Macrolides (Erythromycin), and Telithromycin. * **Cardiovascular Drugs:** Beta-blockers, Quinidine, Procainamide, and Calcium Channel Blockers. * **Neuromuscular Blockers:** Both depolarizing (Succinylcholine) and non-depolarizing (Vecuronium) agents must be used with extreme caution. * **Magnesium salts:** High magnesium levels inhibit ACh release. * **Management Tip:** If a patient on aminoglycosides develops respiratory distress, **Intravenous Calcium Gluconate** can partially reverse the neuromuscular blockade by antagonizing the inhibitory effect on calcium channels.

Q: Moxidectin was approved by FDA recently for which condition?

Onchocerca volvulus. **Explanation:** **Moxidectin** is a potent second-generation macrocyclic lactone (derived from milbemycin) that was FDA-approved in 2018 for the treatment of **Onchocerciasis (River Blindness)** in patients aged 12 years and older. 1. **Why Option B is Correct:** Onchocerciasis is caused by the nematode *Onchocerca volvulus*. While Ivermectin has been the standard of care, Moxidectin has a longer half-life (approx. 20–43 days) and is more effective at suppressing microfilarial levels in the skin for longer periods. It works by binding to glutamate-gated chloride channels, leading to hyperpolarization and paralysis of the parasite. 2. **Why Other Options are Incorrect:** * **Filariasis (Option A):** While Moxidectin is being studied for Lymphatic Filariasis (*W. bancrofti*), the specific recent FDA approval is specifically for Onchocerciasis. Diethylcarbamazine (DEC) remains a primary treatment for Filariasis. * **Hypertension (Option C):** This is a cardiovascular condition. Moxidectin has no antihypertensive properties. * **Scabies (Option D):** Ivermectin (oral) and Permethrin (topical) are the FDA-approved treatments for Scabies. Moxidectin is used off-label or in veterinary medicine for mites but lacks specific FDA approval for human scabies. **High-Yield Clinical Pearls for NEET-PG:** * **Superiority:** Moxidectin is superior to Ivermectin because it is not a substrate for P-glycoprotein pumps, meaning the parasite cannot easily pump the drug out. * **Dosage:** It is administered as a **single oral dose** (8 mg). * **Mazzotti Reaction:** Like Ivermectin, Moxidectin can trigger a Mazzotti reaction (itching, rash, fever) due to the rapid death of microfilariae, though it is generally well-tolerated.

Q: Which one of the following anti-tuberculous drugs has excellent penetration into the cerebrospinal fluid?

Pyrazinamide. **Explanation:** The penetration of anti-tuberculous drugs into the cerebrospinal fluid (CSF) is a critical factor in treating Tuberculous Meningitis (TBM). **Pyrazinamide** is the correct answer because it is a small, highly polar molecule that achieves excellent CSF concentrations, nearly equal to its plasma levels (90–100% penetration), regardless of whether the meninges are inflamed or intact. This makes it a cornerstone in the initial phase of TBM treatment. **Analysis of Incorrect Options:** * **Ethambutol (A):** It has very poor CSF penetration (approx. 10–25%) and only crosses the blood-brain barrier significantly when the meninges are acutely inflamed. * **Streptomycin (C):** As an aminoglycoside, it is a large, polar cation that does not cross the blood-brain barrier effectively. It reaches therapeutic levels in the CSF only in the presence of severe meningeal inflammation. * **Rifampicin (D):** Despite being highly lipid-soluble, it is highly protein-bound and a substrate for P-glycoprotein efflux pumps, resulting in relatively low CSF penetration (approx. 5–20% of plasma levels). **NEET-PG High-Yield Pearls:** * **Isoniazid (INH)** and **Pyrazinamide** are the two primary first-line drugs with excellent CSF penetration. * **Fluoroquinolones** (like Levofloxacin) also show good CSF penetration and are often used in drug-resistant TBM. * For TBM, the WHO recommends a 12-month treatment regimen (2 months of HRZE followed by 10 months of HR). * **Corticosteroids** (Dexamethasone) are always added to TBM treatment to reduce perivascular inflammation and intracranial pressure.

Question 1

Which of the following is a true statement about Imipenem?

Accepted Answer

It is used with cilastatin.

Answer

It has a narrow spectrum of action.

Answer

It is easily broken by beta-lactamase.

Answer

It is used with sulbactam.

Question 2

Which drug is used for the prophylaxis of rheumatic heart disease?

Accepted Answer

All of the above

Answer

Sulfadiazine

Answer

Phenoxy-methyl penicillin

Answer

Benzathine penicillin

Question 3

Which anti-tubercular agent is associated with side effects such as respiratory syndrome, cutaneous syndrome, flu-like syndrome, and abdominal syndrome?

Accepted Answer

Rifampicin

Answer

PAS

Answer

Pyrazinamide

Answer

Streptomycin

Question 4

What is the treatment of choice for luminal infection of E. histolytica?

Accepted Answer

Paromomycin

Answer

Tinidazole

Answer

Metronidazole

Answer

Ivermectin

Question 5

Empirical use of intravenous amphotericin B is indicated in?

Accepted Answer

Non-responding febrile neutropenia

Answer

Candida infections

Answer

Blastomycosis

Answer

Larva migrans

Question 6

Which drug can be safely used in lactating mothers?

Accepted Answer

Erythromycin

Answer

Ampicillin

Answer

Chloramphenicol

Answer

Ciprofloxacin

Question 7

A patient with febrile neutropenia has a blood culture that grew Pseudomonas aeruginosa. The isolate was found to be a producer of extended-spectrum beta-lactamase (ESBL) enzyme. What is the most appropriate antimicrobial therapy?

Accepted Answer

Imipenem + amikacin

Answer

Ceftazidime + amikacin

Answer

Aztreonam + amikacin

Answer

Cefpirome + amikacin

Question 8

Which of the following is contraindicated in a patient with Myasthenia Gravis?

Accepted Answer

Aminoglycosides

Answer

Sulfonamides

Answer

Penicillin

Answer

All the above

Question 9

Moxidectin was approved by FDA recently for which condition?

Accepted Answer

Onchocerca volvulus

Answer

Filariasis

Answer

Hypertension

Answer

Scabies

Question 10

Which one of the following anti-tuberculous drugs has excellent penetration into the cerebrospinal fluid?

Accepted Answer

Pyrazinamide

Answer

Ethambutol

Answer

Streptomycin

Answer

Rifampicin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?